Skip to main content
2024 ACRO Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Charles B. Simone, II, MD, FASTRO, FACRO

Professor and Chief Medical Officer
New York Proton Center/Memorial Sloan Kettering Cancer Center
New York, New York, United States

Charles B. Simone, II, MD, FASTRO, FACRO is Research Professor and Chief Medical Officer of the New York Proton Center. He is also a Full Member in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center. He is an internationally recognized expert in proton therapy and SBRT to treat thoracic malignancies and reirradiation, and in developing innovative clinical trial strategies in thoracic oncology. He was previously Chief of the Thoracic Oncology Service, Director of the Penn Mesothelioma and Pleural Program, and Director of Clinical Research and Operations in Radiation Oncology at University of Pennsylvania. He then became Medical Director of Maryland Proton Treatment Center. At Maryland, he was also Chair of the Clinical Research Committee for their Comprehensive Cancer Center, proton therapy Fellowship Director, and Director of Stereotactic Radiation Therapy. He completed his undergraduate and medical training at UPenn and radiation oncology residency at NCI/NIH, where he was chief resident.
Dr. Simone is an NIH, National Science Foundation, and DOD-funded investigator who has published >560 peer-reviewed scientific articles/chapters, given >485 national/international scientific lectures. He is the national Principal Investigator or Co-Chair of 8 NIH-funded cooperative group trials (NRG Oncology=5, SWOG=1, ECOG-ACRIN=1, PCG=1). He is a three-time winner of the Association of Residents in Radiation Oncology Educator of the Year Award.

Dr. Simone is the Proton Collaborative Group (PCG) Board of Directors President. He Chairs: PCG Lung Committee; NRG Oncology Particle Therapy Work Group; American Society for Radiation Oncology (ASTRO) Lung Resource Panel Committee; ASTRO Blue Ribbon Lung Panel; American Radium Society Appropriate Use Criteria Thoracic Committee; American College of Radiation Oncology Scientific Program Committee; Particle Therapy Co-Operative Group Gastrointestinal Subcommittee; NCI/Radiosurgery Society GRID-Lattice-Microbeam-Flash Radiotherapy Clinical Working Group; FlashForward Consortium Clinical Committee; and Varian Proton Connect Users Group. He is Editor-in-Chief of Annals of Palliative Medicine.

Disclosure(s): No financial relationships to disclose

Presentation(s):

Email Charles